Company: TELO
Filing Date: 2025-11-28
Form Type: PRER14A
Source: 0001493152-25-025406
Chunk: 76

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-11-28
Form: PRER14A
Chunk 76
---
 therapeutics market was valued at USD 31.5 billion in 2024 and is projected to reach USD 71.3 billion by 2034, a compound annual growth rate (CAGR) of 8.5% (Breast Cancer Therapeutics Market Size – Trends Analysis Report, 2034). Breast cancer now represents over 25% of new female cancer cases and 11.7% of all new cancers worldwide, contributing approximately $1.96 trillion to the projected $25.2 trillion global economic cost of cancer by 2050 (https://jamanetwork.com/journals/jamaoncology/fullarticle/2801798).

| 43 |

Globally, breast cancer is the most common cancer in women in 157 of 185 countries. The rising incidence drives increasing demand for treatment services—from surgery, radiation and systemic therapy, to supportive and palliative care. One market-report estimates the total global breast cancer treatment market to grow from USD ≈ 19.24 billion in 2019 to about USD 34.06 billion by 2026, at ~8.5 % CAGR. [PR Newswire] In many regions outside North America, the growth is especially rapid: for example, in Asia-Pacific countries the breast cancer therapeutics market is projected to expand strongly (e.g., India with a CAGR ~15.9%, China ~14.4%) according to one dataset.

Regional differences in demand and treatment dynamics

While demand is global, the character of demand differs significantly by region.

Europe: Europe holds a strong share of the global market. For example, one report shows Europe accounting for roughly 28 % of the global breast cancer drugs market. [Global Growth Insights] In mature European health systems, demand is driven by early detection, access to advanced therapies, and demographic shifts (ageing population).

Asia-Pacific: This region is emerging as a high-growth zone for breast cancer treatment demand. One report states Asia-Pacific holds around 24 % of the global breast cancer diagnostics market in 2025. [Global Growth Insights]. In major countries like China and India, the rising incidence, expanding healthcare infrastructure, and increasing awareness are creating large treatment demand. For example, China’s breast-cancer therapeutics market in 2022 was estimated at USD 146.3 billion (in one data table) with growth forecast to 2030. [Insights 10]

Latin America / Central & South America: Though less extensively profiled in some reports, emerging markets